Differential effects of Ca2+, EDTA and adrenergic blocking agents on the actions of some hormones on adenosine 3',5'-monophosphate levels in isolated adipose cells as determined by prior labeling with [8-14C] adenine.
D000225:Adenine / Q000378:metabolism*; D000227:Adenine Nucleotides / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000494:pharmacology*; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000378:metabolism; D004492:Edetic Acid / Q000494:pharmacology*; D005934:Glucagon / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology*; D066298:In Vitro Techniques; D007986:Luteinizing Hormone / Q000494:pharmacology; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D013972:Thyrotropin / Q000494:pharmacology
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D006728:Hormones; D009539:Nicotinic Acids; D010627:Phenethylamines; D013565:Sympatholytics; D010643:Phenoxybenzamine; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D013972:Thyrotropin; D005934:Glucagon; D004492:Edetic Acid; D011433:Propranolol; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D000225:Adenine; D002118:Calcium; D009638:Norepinephrine